DNTH vs WELL · rev $6.2M vs P/E 100, rev $10.84B
Dianthus Therapeutics Inc. (DNTH) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
DNTH currently screens at market cap $4.40B. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the DNTH and WELL stock pages for the full models.
Not investment advice.